Ossiam Bristol Myers Squibb CO Transaction History

Ossiam

$5.1 Billion
Q3 2024

A detailed history of Ossiam transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ossiam holds 59,969 shares of BMY stock, worth $3.41 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

59,969

Previous 89,984 33.36%

Holding current value

$3.41 Million

Previous $3.74 Million 16.97%

% of portfolio

0.06%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$39.66 - $51.75 $1.19 Million - $1.55 Million	-30,015 Reduced 33.36%	59,969 $3.1 Million
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $72,490 - $95,434	1,801 Added 2.04%	89,984 $3.74 Million
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $1.02 Million - $1.16 Million	21,234 Added 31.72%	88,183 $4.78 Million
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $1.09 Million - $1.3 Million	-22,440 Reduced 25.1%	66,949 $3.44 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $1.06 Million - $1.19 Million	18,315 Added 25.77%	89,389 $5.19 Million
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $112,002 - $124,360	1,758 Added 2.54%	71,074 $4.55 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $267,768 - $303,709	-4,075 Reduced 5.55%	69,316 $4.8 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $53,277 - $63,088	-778 Reduced 1.05%	73,391 $5.28 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $2,907 - $1.72 Million	-22,362 Reduced 23.17%	74,169 $5.27 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $7.66 Million - $8.44 Million	-105,467 Reduced 52.21%	96,531 $7.43 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $7.31 Million - $8.77 Million	118,924 Added 143.15%	201,998 $14.8 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $3.61 Million - $4.2 Million	-67,250 Reduced 44.74%	83,074 $5.18 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $20 Million - $23.5 Million	-338,788 Reduced 69.27%	150,324 $8.9 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $21 Million - $22.9 Million	339,269 Added 226.42%	489,112 $33.2 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $4.89 Million - $5.5 Million	82,351 Added 122.02%	149,843 $9.46 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $1.79 Million - $2.03 Million	-31,082 Reduced 31.53%	67,492 $4.19 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $1.01 Million - $1.12 Million	-17,644 Reduced 15.18%	98,574 $5.94 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $746,155 - $872,328	-13,611 Reduced 10.48%	116,218 $6.83 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $3.02 Million - $4.39 Million	65,095 Added 100.56%	129,829 $7.24 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $824,169 - $1.08 Million	16,748 Added 34.9%	64,734 $4.16 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $1.15 Million - $1.37 Million	26,987 Added 128.52%	47,986 $2.43 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $311,402 - $344,343	6,979 Added 49.78%	20,999 $952,000
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $2 Million - $2.38 Million	-44,289 Reduced 75.96%	14,020 $669,000
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $2.84 Million - $3.69 Million	58,309 New	58,309 $3.03 Million

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.

Account